RACHEL HURTUBISE: Open Payments
NPI 1033990833 · WASHINGTON TOWNSHIP, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,598 in 127 payments from 24 companies in 2025. Trend: 2023 $520 · 2024 $3,010 · 2025 $2,598
Food & beverage: $2,598
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $518 |
| UCB, Inc. | 15 | $281 |
| Lilly USA, LLC | 9 | $255 |
| Alexion Pharmaceuticals, Inc. | 7 | $173 |
| PFIZER INC. | 14 | $165 |
| Neurocrine BioSciences, Inc. | 10 | $155 |
| Eisai Inc. | 2 | $146 |
| Genentech USA, Inc. | 4 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $98 |
| ACADIA Pharmaceuticals Inc | 5 | $96 |
Products named: QULIPTA, ULTOMIRIS, INGREZZA, NURTEC ODT, BOTOX, Leqembi, KISUNLA, Fintepla.
Industry payments across OH — which companies pay providers there.
